Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Gynecol Oncol. 2023 Feb 16;171:15–22. doi: 10.1016/j.ygyno.2023.01.037

Figure 4: Relative gene set enrichment of selected immunoregulatory markers in ECs stratified by molecular subtype.

Figure 4:

Comparison of selected immunoregulatory marker enrichment using ssGSEA including angiogenesis, CTLA4, PD1 and PD-L1. Subgroups were compared using Wilcoxon rank-sum. Statistical significance was defined as a p<0.05 and annotated in the figure with ***P<0.001, **P<0.01, *P<0.05. Comparisons not annotated were not statistically significant.